The automated cell cultures market is experiencing rapid growth due to its ability to provide efficient and reliable cell cultivation and analysis. Automation offers benefits such as increased throughput, reproducibility, and precise control over culture conditions. With advancements in biotechnology research and the rising demand for cell-based therapies and drug discovery, the market is poised for expansion. Integration of artificial intelligence and machine learning further enhances the capabilities of these systems, driving their adoption in various applications.
Access Full Report @ https://www.databridgemarketresearch.com/zh/reports/global-automated-cell-cultures-market
Data Bridge Market Research analyses that the Automated Cell Cultures Market is expected to reach the value of Euro 19,891.20 million by 2029, at a CAGR of 8.9% during the forecast period. The continuous progress in biotechnology and pharmaceutical research drives the demand for automated cell culture systems. These technologies enable researchers to streamline processes, improve reproducibility, and enhance efficiency in cell culture experiments.
Increasing adoption of 3D cell cultures is expected to drive the market's growth rate
The increasing adoption of 3D cell cultures in research and drug discovery is driven by their ability to better mimic the complex cellular environments found in the human body. In order to meet the demand for reliable and reproducible 3D cell culture experiments, automated systems are being employed. These systems offer precise control over parameters such as nutrient supply, oxygen levels, and cell seeding, ensuring consistent and accurate results in 3D cell culture studies drives the market of automated cell cultures market.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in Euro Million, Volumes in Units, Pricing in Euro
|
|
Segments Covered
|
Product (Consumables, Instruments), Type (Infinite Cell Line Cultures, Finite Cell Line Cultures), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, Other)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Sartorius AG (Germany), Danaher. (U.S.), Lonza (Switzerland), Nexcelom Bioscience LLC. (U.S.), HiMedia Laboratories (India), Cell Culture Company, LLC (U.S.), Advanced Instruments (U.S.), SHIBUYA CORPORATION (Japan), NanoEntek (South Korea), FUJIFILM Holdings America Corporation (U.S.), Hitachi, Ltd. (U.S.), Kawasaki Heavy Industries, ltd. (Japan), Sphere Fluidics Limited (U.K.), Thrive Bioscience (U.S.), Eppendorf AG (Germany), CellGenix GmbH (Germany), ChemoMetec (Denmark), PromoCell GmbH (Germany), Thermo Fisher Scientific (U.S.), BioSpherix, Ltd. (U.S.), Merck KGaA (Germany), Tecan Trading AG (Switzerland), Hamilton Company (U.S.), BD (U.S.), Benchmark scientific, Inc. (U.S.), Biotron Healthcare. (India), RWD Life Science Co., LTD (U.S.), Corning Incorporated (U.S.), Bulldog-Bio. (U.S.), and Sphere Fluidics Limited (U.K.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The automated cell cultures market is segmented on the basis of product, type, application, and end user.
- On the basis of product, the global automated cell cultures market is segmented into consumables and instruments. The consumables segment is expected to dominate the global automated cell cultures market with a CAGR of 9.4% in the forecast period of 2022 to 2029 due to the ongoing subscription or licensing fees associated with the software. These fees cover the usage and access to the software solution, including updates, maintenance, and customer support.
In 2022, the consumables segment is expected to dominate the product segment of the global automated cell cultures market
In 2022 the consumables segment is expected to dominate the global automated cell cultures market owing to the growing demand for cell culture technology in vaccine production. Additionally, advancements in cell culture techniques and the growing adoption of automated systems drive the demand for consumables. Therefore, the consumables segment holds a significant share in the automated cell cultures market with a CAGR of 9.4% in the forecast period of 2022 to 2029.
- On the basis of type, the global automated cell cultures market is segmented into finite cell line cultures and infinite cell line cultures. The infinite cell line cultures segment is expected to dominate the global automated cell cultures market with a CAGR of 9.5% in the forecast period of 2022 to 2029 due to technological advancements in cell culture technology systems.
- On the basis of application, the global automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccines, and others. Drug development segment is expected to dominate the global automated cell cultures market with a CAGR of 8.4% in the forecast period of 2022 to 2029 due to favorable government initiatives.
In 2022, the drug development segment is expected to dominate the application segment of the global automated cell cultures market
In 2022, the drug development segment is expected to dominate the global automated cell cultures market owing to the favorable government initiatives and the extensive use of automated cell culture systems in the pharmaceutical industry for drug screening, toxicity testing, and efficacy evaluation with a CAGR of 8.4% in the forecast period of 2022 to 2029.
- On the basis of end user, the global automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes, and others. Biotech companies segment is expected to dominate the global automated cell cultures market with a CAGR of 10.6% in the forecast period of 2022 to 2029 due to commercial entities engaged in biotechnology research, development, and manufacturing of products for medical and scientific purposes.
Major Players
Data Bridge Market Research recognizes the following companies as the major automated cell cultures market players in automated cell cultures market are Sartorius AG (Germany), Danaher. (U.S.), Lonza (Switzerland), Nexcelom Bioscience LLC. (U.S.), HiMedia Laboratories (India), Cell Culture Company, LLC (U.S.), Advanced Instruments (U.S.), SHIBUYA CORPORATION (Japan), NanoEntek (South Korea), FUJIFILM Holdings America Corporation (U.S.), Hitachi, Ltd. (U.S.).
Market Development
- In 2021, An updated online marketplace for flow cytometry has been introduced by BD as bdbiosciences.com. The new website offers flow cytometry users and their procurement teams an improved online shopping experience.
- In 2021, The execution of a definitive agreement for the acquisition of Solentim, a reputable global leader in solutions for the isolation and characterization of high-value single-cell clones in cell line development (CLD) applications, was announced by Advanced Instruments.
- In 2021, Lonza, a global manufacturing partner to the pharma, biotech, and nutrition industries, announced that it would invest in establishing drug product manufacturing capabilities at its site in Guangzhou, China.
- In 2021, Thermo Fisher Scientific Inc entered into a definitive agreement with PPD, Inc. According to the agreement, the company will acquire PPD, Inc. for USD 47.50/share of a total worth of USD 17.4 Billion.
- In 2020, Eppendorf AG announced that it had launched epServices to calibrate pipettes, check the security of centrifuges, or verify the temperatures of PCR cycler. To make it even easier to get an overview of all offered services, users can now find the whole epServices portfolio in the Eppendorf app.
Regional Analysis
Geographically, the countries covered in the automated cell cultures market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in automated cell cultures market during the forecast period 2022 to 2029
North America's dominates in the automated cell cultures market can be attributed to its significant investments in the field of life sciences. The region's pharmaceutical and biotechnological industries are increasing their funding for lab consumables, specifically for research and development purposes. This substantial investment, coupled with the growing demand for automated cell culture systems, is expected to drive the market's growth in North America during the forecast period.
Asia-Pacific is estimated to be the fastest growing region in automated cell cultures market the forecast period 2022 to 2029
Asia-Pacific is expected to experience substantial growth in the automated cell cultures market during the forecast period. This growth can be attributed to the region's increasing focus on improving productivity in various industries, including pharmaceuticals and biotechnology. The adoption of automated cell culture systems allows for higher throughput and efficiency, resulting in enhanced productivity. As a result, the demand for automated cell cultures in the Asia-Pacific region is anticipated to rise significantly in the coming years.
For more detailed information about the automated cell cultures market report, click here – https://www.databridgemarketresearch.com/zh/reports/global-automated-cell-cultures-market
